A Irimie, P Achimas-Cadariu, C Burz… - … of Gastrointestinal & …, 2010 - academia.edu
Background: A literature review on 1,104 269 cancer patients concluded that the prevalence of multiple primary malignancies (MPM) is between 0.73% and 11.7%. MPMs seem to have …
RESUMEN el avance en el conocimiento de la fisiopatología del mieloma múltiple ha permitido el acercamiento a la comprensión de su heterogeneidad, en términos del …
W Lu-Qun, L Hao, L Xiang-Xin, L Fang-Lin… - BMC cancer, 2015 - Springer
Background Although the occurrence of acute myeloid leukemia (AML) after chemotherapy for multiple myeloma (MM) is common in clinical settings, the simultaneous occurrence of …
The advance in the knowledge of the pathophysiology of multiple myeloma has allowed the approach to the understanding of its heterogeneity in terms of clinical, cytomorphological …
E Namal, ÖP Cerci̇z, E Gökmen - Turkish Journal of Oncology, 2016 - onkoloji.dergisi.org
While multiple primary tumors are rarely reported in literature, we expect that it will be seen more often in the future as a result of improvements in diagnosis and treatment of cancer …
Cancer is a growing and evolving epidemic. Multiple primary malignancies is a documented entity and can be synchronous or metachronous depending on the time of diagnosis of the …
T Kittisiam, S Muangkhoua… - … Journal: Journal of …, 2018 - he02.tci-thaijo.org
Objective: To study the prevalence of other cancers in patients with ovarian cancer and history of cancer in their families Methods: The patients with cancers of ovary who were …